53 completed, 11 unknown, 6 recruiting, 4 not yet recruiting. 44 Not applicable, 12 Phase 2, 12 Phase 3, 3 Phase 1, 2 Phase 4.
Follow Universidad Peruana Cayetano Heredia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oxfendazole in Mild Parenchymal Brain Cysticercosis Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis | Phase 2 / Phase 3 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 544 | 2026-12-01 | 2026-05-01 |
| One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis Oxfendazole, Triclabendazole - Fascioliasis | Phase 2 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 336 | 2026-08-15 | 2026-06-03 |
| Bioneer Q-RFIA Clinical Evaluation Estimate the diagnostic accuracy of the Bioneer Accupower Q-RFIA PCR kit on IRON qPCR for MTB detection using culture as reference standard. Estimate the diagnostic accuracy of the Bioneer Ac - Tuberculosis, Multidrug-Resistant | Recruiting | Foundation for Innovative New Diagnostics, Switzerland | 2350 | 2026-06-30 | 2026-09-23 | |
| Improving Menstrual and VAginal Health for All Menstrual Pads, Menstrual Cups, Tampons - Effects of Menstrual Products on the Vaginal Microbiome | Not applicable | Recruiting | Swiss Tropical & Public Health Institute | 100 | 2026-04-15 | 2026-04-23 |
| Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries Co-creation (2016 to 2019) + Co-design (2023 to 2024), Co-design only (2023 to 2024) - Hypertension, Diabetes Mellitus | Not applicable | Not yet recruiting | Universidad Peruana Cayetano Heredia | 2094 | 2025-05-17 | 2025-05-25 |
| Gamified Web-Based Mindfulness for University Student Stress Gamified Digital Mindfulness Intervention, Informational Article - Stress | Not applicable | Completed | Universidad Peruana Cayetano Heredia | 20 | 2024-12-09 | 2026-09-14 |
| FocaL Mass Drug Administration for Vivax Malaria Elimination Focal Mass Drug Administration (fMDA) - Plasmodium Vivax Malaria, Malaria | Phase 3 | Recruiting | University of California, San Francisco | 7530 | 2024-10-14 | 2026-06-09 |
| Genomic Approaches to Dissect Human Host-pathogen Interactions in the Amazonian Rainforest Host-Pathogen Interactions | Unknown | Universidad Peruana Cayetano Heredia | 300 | 2024-08-02 | 2024-04-24 | |
| Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults Oxfendazole, Albendazole - Trichuris Infection | Phase 2 | Not yet recruiting | Oxfendazole Development Group | 250 | 2024-07-01 | 2023-11-08 |
| Diagnostic Innovations for Pediatric Tuberculosis in Bolivia Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_ - Tuberculosis | Recruiting | Tulane University | 1220 | 2024-04-15 | 2026-10-13 | |
| WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru Self-designed messages, Standardized messages - HIV | Not applicable | Active not recruiting | Universidad Peruana Cayetano Heredia | 131 | 2024-03-15 | 2025-03-26 |
| Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru Tafenoquine (TQ) - Malaria, Vivax | Completed | Medicines for Malaria Venture | 187 | 2023-08-28 | 2026-03-20 | |
| Addressing HyperteNsion and Diabetes Through Community-Engaged Systems in Puno, Peru (ANDES Study) ANDES INTERVENTION - Hypertension, Diabetes | Not applicable | Active not recruiting | Universidad Peruana Cayetano Heredia | 1068 | 2023-03-20 | 2026-10-09 |
| Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru Para ti, para mi, para nosotros (P3), Waitlist Control Para ti, para mi, para nosotros (P3) - HIV Infections, Hiv | Not applicable | Completed | Florida International University | 148 | 2022-12-27 | 2025-07-28 |
| Abbott NxTekTM Malaria RDT WHO Prequalification Study Rapid Diagnostic Test - Malaria, RDT | Completed | Foundation for Innovative New Diagnostics, Switzerland | 4563 | 2022-06-30 | 2023-10-13 | |
| Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine Colposcopy using pocket colpscope and thermocoagulator - Cervical Cancer, HPV Infection | Not applicable | Completed | Duke University | 503 | 2022-05-01 | 2024-07-23 |
| CBT and Quality of Life of People With HIV, COVID-19 and Anxiety or Depression Trial-based Cognitive therapy - Quality of Life, Anxiety | Not applicable | Unknown | Universidad Peruana Cayetano Heredia | 182 | 2022-03-01 | 2022-03-31 |
| A Mobile Phone SMS Intervention to Increase Retention in HIV Care Among HIV-Positive MSM in Peru (WELTEL PERU) SMS - Retention in Care, Hiv | Not applicable | Completed | Universidad Peruana Cayetano Heredia | 208 | 2022-01-31 | 2025-05-30 |
| SANCC: Clinical Trial Early Intervention Albendazole - Subarachnoid Neurocysticercosis | Phase 2 | Withdrawn | Oregon Health and Science University | 2022-01-01 | 2022-04-12 | |
| Digital Support Systems to Improve Child Health and Development in Peru Home visits, Afini App - Child Development | Not applicable | Recruiting | Swiss Tropical & Public Health Institute | 2400 | 2021-09-01 | 2025-05-18 |
Showing 20 of 84. Sign in to see all of them.
COVID-19 (8) · Hypertension (8) · Diabetes Mellitus (5) · Neurocysticercosis (5) · Acquired Immunodeficiency Syndrome (4) · Altitude Sickness (4) · Tuberculosis (4) · Depression (3) · HIV Infections (3) · Health Behavior (3) · Malaria (3) · Polycythemia (3) · Tuberculosis, Pulmonary (3) · Anemia, Iron-Deficiency (2) · Behavior (2)
Albendazole (6) · oxfendazole (5) · Acetazolamide (3) · Lactoferrin (3) · maltodextrin (3) · Praziquantel (2) · AIDS Serodiagnosis (1) · Acetylcysteine (1) · Cefixime (1) · Chlorhexidine (1) · Dexamethasone (1) · Diagnostic Imaging (1) · Ethanol (1) · Ferric Oxide, Saccharated (1) · Food, Fortified (1)
Peru (66) · Nepal (4) · Guatemala (2) · India (2) · Indonesia (2) · Kenya (2) · Switzerland (2) · Uganda (2) · United States (2) · Argentina (1) · Bolivia (1) · Brazil (1) · Cameroon (1) · Ethiopia (1) · Moldova (1)
Eduardo Gotuzzo, MD (4) · Jaime Miranda, MD, PhD (4) · Robert H Gilman, MD (3) · William Checkley, MD, PhD (3) · Alejandro Llanos-Cuentas, MD, PhD (2) · Hector H Garcia, MD PhD (2) · Hector H Garcia, MD, PhD (2) · Lisa Colpe, PhD (2) · Peter Milgrom, DDS (2) · Theresa J Ochoa, MD (2) · Abdias Hurtado, MD (1) · Adriana Romo, DDS (1) · Alejandro Llanos, MD, PhD (1) · Andres G Lescano, PhD, MHS (1) · Antonio Bernabe-Ortiz, MD, MPH (1)
PMID 30340648, PMID 33546709, PMID 33974019, PMID 34643538, PMID 38345934, PMID 12522449, PMID 15100608, PMID 15472843, PMID 15883236, PMID 16046874, PMID 17099312, PMID 17376384, PMID 18047578, PMID 18388356, PMID 18719057, PMID 19578703, PMID 19809026, PMID 20061510, PMID 20573027, PMID 20705402, PMID 21332573, PMID 21343468, PMID 21390262, PMID 21965433, PMID 22227566, PMID 23065532, PMID 23272643, PMID 23320116, PMID 23349670, PMID 24028778, PMID 24112419, PMID 24999157, PMID 25227629, PMID 25300577, PMID 25367444, PMID 25973934, PMID 26109173, PMID 26225848, PMID 26653067, PMID 26786489, PMID 26818683, PMID 26984901, PMID 27215561, PMID 28125095, PMID 28678190, PMID 28950912, PMID 29070638, PMID 29417019, PMID 29495948, PMID 29510682
U19MH098780 (2), 1UM1HL134590-01 (1), D43TW009763 (1), K43TW011428 (1), R01HD067694 (1), R01NS054805 (1), R01NS103623 (1), R01TW007896 (1), U01AI155323 (1), U01AI157962 (1), UG3HL152371 (1)